These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31885954)

  • 1. Secondary Squamous Cell Carcinoma of the Tongue Complicated with Bronchiolitis Obliterans as a Manifestation of Graft-versus-Host Disease following Peripheral Blood Stem Cell Transplantation.
    Hashimoto K; Nagao T; Koie S; Miyabe S; Saito T
    Case Rep Hematol; 2019; 2019():6015803. PubMed ID: 31885954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P16-positive secondary tongue squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: A case report and literature review.
    Wu T; Liu Z; Yong X; Mei G; Jiang Q; Fang M; Li P; Zhang Z; Tao R
    Oral Oncol; 2021 Oct; 121():105399. PubMed ID: 34217620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous blood pleurodesis for pneumothorax complicating graft-versus-host disease-related bronchiolitis obliterans.
    Chadwick C; Marven SM; Vora AJ
    Bone Marrow Transplant; 2004 Feb; 33(4):451-3. PubMed ID: 14716352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
    Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF
    Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-specific interstitial pneumonia as a manifestation of graft-versus-host disease following pediatric allogeneic hematopoietic stem cell transplantation.
    Miyagawa-Hayashino A; Sonobe M; Kubo T; Yoshizawa A; Date H; Manabe T
    Pathol Int; 2010 Feb; 60(2):137-42. PubMed ID: 20398200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
    Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W
    Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation.
    Uhlving HH; Andersen CB; Christensen IJ; Gormsen M; Pedersen KD; Buchvald F; Heilmann C; Nielsen KG; Mortensen J; Moser C; Sengeløv H; Müller KG
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):531-8. PubMed ID: 25498923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lichenoid nail changes as sole external manifestation of graft vs. host disease.
    Palencia SI; Rodríguez-Peralto JL; Castaño E; Vanaclocha F; Iglesias L
    Int J Dermatol; 2002 Jan; 41(1):44-5. PubMed ID: 11895513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma of the tongue complicating chronic oral mucosal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Szeto CH; Shek TW; Lie AK; Au WY; Yuen AP; Kwong YL
    Am J Hematol; 2004 Oct; 77(2):200-2. PubMed ID: 15389910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on graft-versus-host disease in the allogeneic peripheral blood stem cell transplantation for the treatment of leukemia].
    Zhang WP; Wang JM; Ju XP; Song XM; Tong SP; Li HM
    Zhonghua Xue Ye Xue Za Zhi; 2003 Mar; 24(3):129-33. PubMed ID: 12697123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new pattern of pulmonary graft vs host disease in a hematopoietic stem cell transplant patient.
    Wahla AS; Khan II; Loya A; Chin R
    Clin Respir J; 2015 Oct; 9(4):399-402. PubMed ID: 24725497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Barotrauma Following Nasal High-Flow Therapy in a Patient with Bronchiolitis Obliterans Syndrome.
    Ito T; Suzuki T; Maeda M; Iwamoto S; Hirayama M; Yamada Y; Azuma E
    Am J Case Rep; 2019 Nov; 20():1619-1622. PubMed ID: 31680117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF.
    Platzbecker U; Thiede C; Freiberg-Richter J; Helwig A; Mohr B; Prange G; Füssel M; Köhler T; Ehninger G; Bornhäuser M
    Ann Hematol; 2001 Mar; 80(3):144-9. PubMed ID: 11320898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin inhibitor--free graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide and brief-course sirolimus following reduced-intensity peripheral blood stem cell transplantation.
    Solomon SR; Sanacore M; Zhang X; Brown S; Holland K; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1828-34. PubMed ID: 25064745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of bronchiolitis obliterans with rapidly progressive bronchiectasis after allogeneic peripheral blood-derived stem cell transplantation].
    Gotoh K; Nakamura T; Emura M; Sakai S; Sugio Y; Cho T
    Nihon Kokyuki Gakkai Zasshi; 2010 Dec; 48(12):960-5. PubMed ID: 21226305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of splenectomy on pancytopenia after a peripheral blood stem cell transplantation.
    Ding J; Bao W; Wang J; Zhao G; Chen J; Song H
    Cell Transplant; 2011; 20(7):1109-15. PubMed ID: 21092413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible clinical benefits of the use of peripheral blood stem cells over bone marrow in the allogeneic transplantation setting for the treatment of childhood leukemia.
    Matsubara H; Makimoto A; Takayama J; Higa T; Saito T; Kanda Y; Tanosaki R; Mineishi S; Ohira M; Takaue Y
    Jpn J Clin Oncol; 2001 Jan; 31(1):30-4. PubMed ID: 11256838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia.
    Santo Tomas LH; Loberiza FR; Klein JP; Layde PM; Lipchik RJ; Rizzo JD; Bredeson CN; Horowitz MM
    Chest; 2005 Jul; 128(1):153-61. PubMed ID: 16002929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filgrastim treatment of acute myelogenous leukemia (M7) relapse after allogeneic peripheral stem cell transplantation resulting in both graft-versus-leukemia effect with cytogenetic remission and chronic graft-versus-host disease manifesting as polyserositis and subsequent bronchiolitis obliterans with organizing pneumonia.
    Law L; Tuscano J; Wun T; Ahlberg K; Richman C
    Int J Hematol; 2002 Nov; 76(4):360-4. PubMed ID: 12463601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.